GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Y

Yuhan 000100.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

77,800

-3.23%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩2.19trn

FY2016FY2025

Net income

₩194.08bn

FY2016FY2025

Free cash flow

−₩38.51bn

FY2016FY2025

Shareholders' equity

₩2.31trn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩2.19trn₩2.07trn₩1.86trn₩1.78trn₩1.69trn₩1.62trn₩1.48trn₩1.52trn₩1.46trn₩1.32trn
Gross profit₩729.92bn₩689.39bn₩565.86bn₩518.20bn₩524.65bn₩558.42bn₩430.85bn₩413.79bn₩424.62bn₩389.44bn
Research and development₩219.71bn₩224.76bn₩119.92bn₩107.10bn₩106.68bn₩142.63bn₩96.90bn₩74.07bn₩71.43bn₩52.67bn
Operating income₩229.91bn₩67.58bn₩57.03bn₩36.03bn₩48.60bn₩84.26bn₩12.54bn₩50.13bn₩88.71bn₩97.79bn
Net income₩194.08bn₩70.69bn₩136.20bn₩95.14bn₩102.58bn₩192.76bn₩40.01bn₩57.48bn₩109.03bn₩161.25bn
Diluted earnings per share3,265.961,189.532,291.941,601.091,726.263,243.78673.22919.1714,530.922,713.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩3.22trn₩2.94trn₩2.81trn₩2.47trn₩2.46trn₩2.39trn₩2.12trn₩2.17trn₩2.09trn₩2.05trn
Total liabilities₩858.64bn₩791.38bn₩711.65bn₩464.92bn₩527.92bn₩547.02bn₩467.21bn₩522.08bn₩488.35bn₩549.39bn
Debt—₩304.56bn₩230.07bn₩99.03bn₩124.77bn₩123.09bn₩91.47bn₩118.58bn₩133.82bn₩196.60bn
Shareholders' equity₩2.31trn₩2.10trn₩2.05trn₩1.99trn₩1.93trn₩1.84trn₩1.65trn₩1.64trn₩1.60trn₩1.50trn
Shares outstanding59m59m59m59m59m59m59m63m8m59m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩106.23bn₩54.60bn₩127.75bn₩99.53bn₩99.00bn₩28.83bn₩65.99bn₩93.45bn₩126.13bn₩74.14bn
Capital spending−₩144.74bn−₩133.92bn−₩72.41bn−₩65.80bn−₩46.15bn−₩51.45bn−₩42.76bn−₩46.00bn−₩56.77bn−₩84.63bn
Free cash flow−₩38.51bn−₩79.31bn₩55.35bn₩33.73bn₩52.85bn−₩22.62bn₩23.22bn₩47.45bn₩69.35bn−₩10.48bn
Dividends paid−₩37.48bn−₩32.15bn−₩27.27bn−₩26.08bn−₩24.94bn−₩23.78bn−₩22.91bn−₩21.94bn−₩20.75bn−₩20.55bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩639.45bn₩526.78bn₩546.07bn₩570.01bn₩578.99bn₩491.56bn₩496.10bn₩598.78bn
Gross profit₩227.96bn₩149.37bn₩213.15bn₩168.88bn₩199.23bn₩148.66bn₩146.69bn₩240.80bn
Operating income₩89.85bn₩8.82bn₩26.08bn₩37.07bn₩53.63bn₩6.42bn−₩42.01bn₩54.22bn
Net income₩70.32bn₩27.04bn₩114.43bn₩25.28bn₩45.53bn₩8.83bn−₩11.51bn₩37.43bn
Diluted earnings per share1,183.40455.091,925.71425.48766.23148.54-193.71629.81
Cash from operations₩43.96bn₩37.15bn₩7.70bn₩76.86bn₩16.76bn₩4.92bn₩53.53bn−₩11.81bn
Capital spending−₩63.14bn−₩24.85bn−₩59.94bn−₩28.81bn−₩26.79bn−₩29.19bn−₩44.30bn−₩38.87bn
Free cash flow−₩19.18bn₩12.30bn−₩52.24bn₩48.04bn−₩10.04bn−₩24.27bn₩9.23bn−₩50.69bn
Total assets₩3.33trn₩3.28trn₩3.22trn₩3.05trn₩3.04trn₩2.99trn₩2.94trn₩2.93trn
Debt₩88.92bn₩91.12bn₩71.12bn₩103.45bn₩127.86bn₩121.89bn₩121.31bn₩127.18bn
Shareholders' equity₩2.39trn₩2.29trn₩2.31trn₩2.16trn₩2.15trn₩2.07trn₩2.10trn₩2.12trn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.2%6.2%6.8%
Operating income85.5%22.2%10.4%
Net income26.8%0.1%4.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.4%31.7%32.0%30.8%
Operating margin7.0%5.0%4.7%4.7%
Net margin6.2%6.3%7.1%7.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings34.4100.530.034.032.620.057.834.92.310.4
Price to sales3.03.42.21.82.02.41.61.30.21.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 26 Feb 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year600.00500.00450.00380.952362.812329.081329.081313.41
  • 1.05-for-1 split · 27 Dec 2023
  • 21-for-20 split · 28 Dec 2022
  • 21-for-20 split · 29 Dec 2021
  • 21-for-20 split · 29 Dec 2020
  • 5-for-1 split · 8 Apr 2020
  • 21-for-20 split · 27 Dec 2019

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.